☰

David Kalant, Ph.D. - Publications

Affiliations: 
2004 Concordia University (Canada), Montreal, QC, Canada 
Area:
Molecular Biology, Pathology, Animal Physiology Biology
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Cui W, Lapointe M, Gauvreau D, Kalant D, Cianflone K. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Molecular Immunology. 46: 3207-17. PMID 19767107 DOI: 10.1016/J.Molimm.2009.08.013  0.54
2007 Cui W, Paglialunga S, Kalant D, Lu H, Roy C, Laplante M, Deshaies Y, Cianflone K. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. American Journal of Physiology. Endocrinology and Metabolism. 293: E1482-91. PMID 17711993 DOI: 10.1152/Ajpendo.00565.2006  0.487
2007 MacLaren R, Kalant D, Cianflone K. The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 85: 11-21. PMID 17464341 DOI: 10.1139/o06-207  0.514
2005 Kalant D, MacLaren R, Cui W, Samanta R, Monk PN, Laporte SA, Cianflone K. C5L2 is a functional receptor for acylation-stimulating protein. The Journal of Biological Chemistry. 280: 23936-44. PMID 15833747 DOI: 10.1074/Jbc.M406921200  0.574
2004 Kalant D, Cianflone K. Regulation of fatty acid transport. Current Opinion in Lipidology. 15: 309-14. PMID 15166787 DOI: 10.1097/00041433-200406000-00011  0.517
2003 Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. The Journal of Biological Chemistry. 278: 11123-9. PMID 12540846 DOI: 10.1074/Jbc.M206169200  0.513
2000 Kalant D, Phélis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD. Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. Journal of Lipid Research. 41: 1963-8. PMID 11108729  0.49
1999 Xiang SQ, Cianflone K, Kalant D, Sniderman AD. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. Journal of Lipid Research. 40: 1655-63. PMID 10484612  0.482
1997 Vu H, Cianflone K, Zhang Z, Kalant D, Sniderman AD. Characterization and modulation of LP(a) in human hepatoma HEPG2 cells. Biochimica Et Biophysica Acta. 1349: 97-108. PMID 9421183 DOI: 10.1016/S0005-2760(97)00125-2  0.508
1996 Cianflone K, Zhang Z, Vu H, Kohen-Avramoglu R, Kalant D, Sniderman AD. The effect of individual amino acids on ApoB100 and Lp(a) secretion by HepG2 cells. The Journal of Biological Chemistry. 271: 29136-45. PMID 8910570 DOI: 10.1074/Jbc.271.46.29136  0.567
1995 Cianflone K, Kalant D, Marliss EB, Gougeon R, Sniderman AD. Response of plasma ASP to a prolonged fast. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 19: 604-9. PMID 8574269  0.449
1994 Zhang Z, Sniderman A, Vu H, Kalant D, Cianflone K. Effect of amino acids on apo B secretion in HepG2 cells Atherosclerosis. 109: 215. DOI: 10.1016/0021-9150(94)93863-6  0.536
1993 Zhang Z, Sniderman AD, Kalant D, Vu H, Monge JC, Tao Y, Cianflone K. The role of amino acids in ApoB100 synthesis and catabolism in human HepG2 cells. The Journal of Biological Chemistry. 268: 26920-6. PMID 8262926  0.559
Show low-probability matches.